Access our on-demand webinar today.
Osteoarthritis is one of the most prevalent, chronic diseases in the world today, causing significant health and socioeconomic problems. However, therapies targeting the etiology of osteoarthritis or reversing structural damage are still lacking.
Preclinical research on osteoarthritis remains challenging because its onset is influenced by different mechanisms, resulting in various symptoms such as joint pain, inflammatory flares, and cartilage lesions. As such, there is not a single preclinical model that encompasses all sequelae of osteoarthritis.
In this webinar, our scientists will discuss various animal models for osteoarthritis drug development and compare lesion morphologies and pathological mediators of osteoarthritis in these models.
This webinar will:
- Highlight the advantages and limitations of current preclinical osteoarthritis models
- Discuss key morphologic and pathogenic features of various osteoarthritis models
- Provide guidance selecting the most applicable osteoarthritis model for drug development
Complete the form to access the on-demand webinar today.
